Dr. David A. Brantley, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 635
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
NC license 9800197
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Tryon Medical PArtners, PLLC (141 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 635
- Services billed
- 5,351
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 5,881 | 63 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,022 | 626 |
| Hemoglobin a1c level | 369 | 257 |
| Thyroxine (thyroid chemical), free | 344 | 258 |
| Blood test, thyroid stimulating hormone (tsh) | 343 | 257 |
| Blood test, comprehensive group of blood chemicals | 291 | 226 |
| Vitamin d-3 level | 276 | 230 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 212 | 114 |
| Injection of drug or substance under skin or into muscle | 123 | 66 |
| Ultrasound scan of head and neck soft tissue | 122 | 117 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Charlotte, NC | 466 |
| Ozempic (semaglutide) Other prescribers in Charlotte, NC | 357 |
| Synthroid (levothyroxine sodium) Other prescribers in Charlotte, NC | 286 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Charlotte, NC | 219 |
| Mounjaro (tirzepatide) Other prescribers in Charlotte, NC | 203 |
| Alendronate Sodium Other prescribers in Charlotte, NC | 167 |
| Rosuvastatin Calcium Other prescribers in Charlotte, NC | 158 |
| Pioglitazone Hcl Other prescribers in Charlotte, NC | 120 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Charlotte, NC | 112 |
| Ezetimibe Other prescribers in Charlotte, NC | 102 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 40 payments worth $1,011 in total to this clinician.
| Novo Nordisk Inc | $335 |
|---|---|
| Radius Health, Inc. | $121 |
| Amgen Inc. | $85.01 |
| Ascendis Pharma Endocrinology Inc | $67.17 |
| Lilly USA, LLC | $58.21 |
| Sanofi-aventis U.S. LLC | $47.29 |
| Bayer HealthCare Pharmaceuticals Inc. | $41.52 |
| AbbVie Inc. | $39.14 |
| Food and Beverage | $1,011 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.